Fahrettin AKAY, Halil GENÇ, Yusuf Çağdaş KUMBUL

Effect Of The Inflammatory Bowel Diseases On Choroidal And Macular Thickness

Objective: Crohn’s disease (CD) and ulcerative colitis (UC) are a group ofinflammatory bowel disease (IBD). Ophthalmic disorders might occur in IBD.The most common findings are episcleritis and uveitis.Then purpose of thestudy was to evaulate the choroidal and macular thickness (MT and CT) inthe IBD and to check it with the disease activity. Methods: IBD group wasincluding 50 patients and the control group consisted of 50 healty volunteers.All participants were tested with spectral domain optical coherence tomography(SD-OCT). The CT values were obtained at seven different points.Results: Mean duration of the IBD was 3.9 ±1.5 years. Foveal macular thicknesswas 258.1 ± 14.2 μm in study group and 262.7 ± 20.9 μm in the controlgroup. There was not significant difference between groups(P=0,19). Subfoveal,temporal 500 μm, 1000 μm, and 1500 μm CT measurements were respectivelystatistically significant in the study group (p

İnflamatuar Bağırsak Hastalıklarının Koroi̇dal ve Makular Kalınlık Üzeri̇ne Etkisi

Amaç: Crohn hastalığı (CD) ve ülseratif kolit (ÜK) bir grup inflamatuar barsak hastalığıdır (IBD) .IBD’de oftalmik bozukluklar ortaya çıkabilir. En sık görülen bulgular episklerit ve üveittir. Çalışmanın amacı IBD’deki koroidal ve maküla kalınlığını (MT ve CT) değerlendirmek ve bunu hastalık aktivitesi ile kontrol etmektir. Yöntem: IBD grubu 50 hastanın 50 sağ gözünü içeriyorken, kontrol grubu ise 50 sağlıklı gönüllünün herhangi bir gözünden oluşmuştu. Tüm katılımcılar spectral domain optical coherence tomography (SD-OCT) ile test edildi. CT değerleri yedi farklı noktada elde edildi. Bulgular: IBD’nin ortalama süresi 3.9 ± 1.5 yıl idi. Foveal maküler kalınlık; çalışma grubunda 258.1 ± 14.2 μm, kontrol grubunda 262.7 ± 20.9 μm idi. Gruplar arasında anlamlı fark yoktu (P = 0,19). Subfoveal, temporal 500 μm, 1000 μm ve 1500 μm CT ölçümleri, çalışma grubunda sırasıyla istatistiksel olarak anlamlıydı (p

PDF

___

Cloche V, Buisson A, Trechot F, Batta B, Locatelli A, Favel C, et al. Ocular symptoms are not predictive of ophthalmologic inflammation in inflammatory bowel disease. Dig Liver Dis. 2013;45(3):195-9.

Banares A, Jover JA, Fernandez-Gutierrez B, Benitez del Castillo JM, Garcia J, Vargas E, et al. Patterns of uveitis as a guide in making rheumatologic and immunologic diagnoses. Arthritis and rheumatism. 1997;40(2):358-70.

Kim M, Kim H, Kwon HJ, Kim SS, Koh HJ, Lee SC. Choroidal thickness in Behcet’s uveitis: an enhanced depth imaging-optical coherence tomography and its association with angiographic changes. Investigative ophthalmology & visual science. 2013;54(9):6033-9.

Gundogan FC, Akay F, Uzun S, Ozge G, Toyran S, Genç H. Choroidal thickness changes in the acute attack period in patients with familial Mediterranean fever. Ophthalmologica Journal international d’ophtalmologie International journal of ophthalmology Zeitschrift fur Augenheilkunde. 2015;235(2):72-7

Baltmr A, Lightman S, Tomkins-Netzer O. Examining the choroid in ocular inflammation: a focus on enhanced depth imaging. Journal of ophthalmology. 2014;2014:459136.

Nickla DL, Wallman J. The multifunctional choroid. Progress in Retinal and Eye Research. 2010;29(2):144-68.

Onal IK, Yuksel E, Bayrakceken K, Demir MM, Karaca EE, Ibis M, et al. Measurement and clinical implications of choroidal thickness in patients with inflammatory bowel disease. Arquivos brasileiros de oftalmologia. 2015;78(5):278-82.

Fong AH, Li KK, Wong D. Choroidal evaluation using enhanced depth imaging spectral-domain optical coherence tomography in Vogt-Koyanagi-Harada disease. Retina (Philadelphia, Pa). 2011;31(3):502-9.

Ishikawa S, Taguchi M, Muraoka T, Sakurai Y, Kanda T, Takeuchi M. Changes in subfoveal choroidal thickness associated with uveitis activity in patients with Behcet’s disease. The British journal of ophthalmology. 2014;98(11):1508-13.

Felekis T, Katsanos K, Kitsanou M, Trakos N, Theopistos V, Christodoulou D, et al. Spectrum and frequency of ophthalmologic manifestations in patients with inflammatory bowel disease: a prospective single- center study. Inflamm Bowel Dis. 2009;15(1):29-34

Troncoso LL, Biancardi AL, de Moraes HV, Jr., Zaltman C. Ophthalmic manifestations in patients with inflammatory bowel disease: A review. World J Gastroenterol. 2017;23(32):5836-48.

Mady R, Grover W, Butrus S. Ocular Complications of Inflammatory Bowel Disease. The Scientific World Journal. 2015;2015:1-5.

Goudet P, Dozois RR, Kelly KA, Ilstrup DM, Phillips SF. Characteristics and evolution of extraintestinal manifestations associated with ulcerative colitis after proctocolectomy. Digestive surgery. 2001;18(1):51-5.

Bernstein CN. Extraintestinal manifestations of inflammatory bowel disease. Current gastroenterology reports. 2001;3(6):477-83.